CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 536 enrolled
Drug / intervention
Questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04849767
NCT04849767N/ACompleted
CompareCT.gov

Trans&VIH: National Survey About Trajectory and Life Conditions of HIV Trans People in France

ANRS, Emerging Infectious Diseases·observational·Posted Apr 19, 2021·Updated Feb 12, 2024

In Brief

An observational study evaluating Questionnaire for HIV Seropositivity. Completed, enrolled 536 participants across 1 site.

Detailed Summary

TRANS\&VIH is a national survey that will explore condition of vulnerability and trajectory of transgender people living with HIV. To fulfill this purpose, clinical data from medical registry and socio-behavioral information collected through questionnaire, will help to explore this questions about vulnerability and condition of transgender people living with HIV.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Seropositivity
CountriesFrance
CollaboratorsInstitut National de la Santé Et de la Recherche Médicale, France

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 19, 2021
Enrollment StartOct 1, 2020
Primary CompletionJul 31, 2022
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.2 years ago

Interventions

Questionnaireother

Questionnaire about socio-behavioral items and conditions of vulnerability. interview with female to male transgender person will be about life conditions, trajectory of the medical transition from female to male and actual medical following of the transition, migration trajectory and condition of HIV acquisition.